Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CTLA4 specificity or anti-PD1 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CTLA4 x Human Anti-PD1 Bispecific Antibody (scFv-Fc) (BSCFV-H315). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS